Halpan-IV Injection
Images are for reference. Actual packaging may vary.
Pantoprazole (40mg)
Vial of 1 injection • Injection
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Pantoprazole irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, leading to decreased gastric acid secretion.
Medical applications
Halpan-IV Injection contains Pantoprazole 40 mg, a proton pump inhibitor used for the treatment of acid-related gastrointestinal conditions. Pantoprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion. Halpan-IV is indicated for the short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and other pathological hypersecretory conditions.
It is also utilized for the prevention and treatment of gastric ulcers, including those induced by nonsteroidal anti-inflammatory drugs (NSAIDs). Administered intravenously, Halpan-IV provides rapid and effective acid suppression, making it suitable for patients unable to take oral medication. The recommended dosage and duration of therapy should be determined by the physician based on the clinical condition of the patient.
Common adverse effects may include headache, diarrhea, nausea, and abdominal pain, though the drug is generally well tolerated. Caution is advised in patients with hepatic impairment, and long-term use requires monitoring for potential vitamin B12 deficiency and hypomagnesemia. Halpan-IV Injection should be used under strict medical supervision to ensure optimal therapeutic outcomes and minimize risks.
Sulfinylbenzimidazole Derivative
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Halpan-IV Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Halpan-IV Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Halpan-IV Injection is safe to use in patients with kidney disease. No dose adjustment of Halpan-IV Injection is recommended.
Exercise Caution
It is not known whether Halpan-IV Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Halpan-IV Injection should be used with caution in patients with severe liver disease. Dose adjustment of Halpan-IV Injection may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Halpan-IV Injection







